Three Space Stories That Matter Now: $RKLB’s Iridium Shock, $ASTS’s August Launch Window, and Rocket Lab’s NASA Credibility Trade. $IRDM

Space Stories

The public space sector just received a concentrated set of catalysts: Rocket Lab is trying to buy an operating satellite communications network, AST SpaceMobile has placed its next BlueBird batch on the launch calendar, and NASA has selected Rocket Lab for dedicated Sun/Earth science missions. Together, these updates show how the investable space trade is moving beyond launch hype and into infrastructure, networks, services, and execution.

Space Stocks Selloff: Why $PL, $LUNR, $SATL, $ASTS and RKLB Are Falling Together After June’s Rally

space

The June space trade is no longer being priced stock by stock. Planet Labs, Intuitive Machines, Satellogic, AST SpaceMobile and Rocket Lab are being traded as one high-beta space basket — and the unwind has exposed the same pressure points across the sector: SpaceX gravity, ETF outflows, valuation resets, execution risk, launch cadence, defense-contract timing and profit-taking after a crowded rally.

4 FDA PDUFA Dates — Week of June 29–30, 2026

4 PDUFA plays

ARQT, LNTH and UNCY face FDA target action dates on June 29, while VRDN follows on June 30. The setup spans pediatric dermatology, nuclear medicine imaging, dialysis-related nephrology and thyroid eye disease — four very different regulatory events with very different trading profiles.

Report date: June 25, 2026
Financial data: latest Q1 2026 updates where available

Ionis Pharmaceuticals (Nasdaq: $IONS): TRYNGOLZA Wins FDA Approval in Severe Hypertriglyceridemia

IONS

The FDA approval of TRYNGOLZA in adults with severe hypertriglyceridemia turns olezarsen from a rare-disease FCS launch into a broader cardiometabolic commercial story. The key issue now is not simply whether the drug works, but how quickly Ionis can convert a stronger label, a larger addressable population and pancreatitis-risk messaging into real prescribing momentum.

HIVE Digital Technologies (Nasdaq/TSX: $HIVE): Bitcoin Mining, AI Infrastructure, Paraguay, Canada and the New Compute Trade

HIVE

HIVE is no longer just a public Bitcoin miner. The company is trying to become a dual-engine digital infrastructure platform, using renewable-powered mining scale, GPU infrastructure and BUZZ HPC to participate in the AI compute boom. The opportunity is real enough to monitor closely, but the equity remains exposed to Bitcoin volatility, dilution, capex intensity and major execution risk.

Definium Therapeutics (Nasdaq: $DFTX): DT120 Phase 3 Emerge Deep Dive After Positive MDD Data

DFTX

Definium has moved from a speculative late-stage psychedelic psychiatry story into a much more serious Phase 3 data story. The positive Emerge readout in major depressive disorder changes the market conversation around DT120 ODT, but it does not remove the key risks: replication, regulatory execution, controlled-substance scheduling, commercial infrastructure, reimbursement and future capital strategy.

$ADXN / $DFTX / $MLTX / $CVM — From the Biotech World Today: Four Smaller Headlines Worth Watching

Biotech Radar

Addex Therapeutics, Definium Therapeutics, MoonLake Immunotherapeutics and CEL-SCI do not belong to the same biotech story. But today’s updates show four very different types of biotech catalysts: a financial and pipeline update, a Phase 3 psychiatry readout event, long-term immunology data tied to a future BLA strategy, and an international commercialization pathway for an investigational oncology asset.

Keel Infrastructure Corp. (Nasdaq/TSX: $KEEL): From Bitcoin Miner To AI Power Infrastructure — A High-Beta Data Center Pivot To Watch

KEEL

Keel Infrastructure is trying to transform the former Bitfarms platform into a North American AI/HPC data center and power infrastructure story. The market narrative is powerful, the asset base is strategically relevant, and the balance sheet has been strengthened — but the investment case still depends on execution, customer leases, capital discipline and proof that megawatts can become durable infrastructure cash flow.